Chemoinformaics analysis of Sophoraisoflavone A
| Molecular Weight | 352.342 | nRot | 1 |
| Heavy Atom Molecular Weight | 336.214 | nRig | 23 |
| Exact Molecular Weight | 352.095 | nRing | 4 |
| Solubility: LogS | -3.516 | nHRing | 2 |
| Solubility: LogP | 4.365 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 42 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 26 | No. of Aromatic Carbocycles | 2 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 17 |
| nHA | 6 | APOL | 48.8807 |
| nHD | 3 | BPOL | 20.3913 |
| QED | 0.616 |
| Synth | 3.063 |
| Natural Product Likeliness | 2.393 |
| NR-PPAR-gamma | 0.983 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.005 |
| Pgp-sub | 0.002 |
| HIA | 0.021 |
| CACO-2 | -4.815 |
| MDCK | 0.0000169 |
| BBB | 0.008 |
| PPB | 0.999264 |
| VDSS | 0.404 |
| FU | 0.0114709 |
| CYP1A2-inh | 0.939 |
| CYP1A2-sub | 0.394 |
| CYP2c19-inh | 0.695 |
| CYP2c19-sub | 0.054 |
| CYP2c9-inh | 0.842 |
| CYP2c9-sub | 0.931 |
| CYP2d6-inh | 0.905 |
| CYP2d6-sub | 0.409 |
| CYP3a4-inh | 0.645 |
| CYP3a4-sub | 0.114 |
| CL | 3.47 |
| T12 | 0.58 |
| hERG | 0.045 |
| Ames | 0.156 |
| ROA | 0.839 |
| SkinSen | 0.881 |
| Carcinogencity | 0.738 |
| EI | 0.787 |
| Respiratory | 0.297 |
| NR-Aromatase | 0.885 |
| Antiviral | Yes |
| Prediction | 0.756829 |